Comparing tapentadol to oxycodone/naloxone combination: imagining castles in the air … while building sandcastles! Re: Coluzzi F, Ruggeri M. Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain. Curr Med Res Opin 2014;30:1139-51

Click to increase image sizeClick to decrease image size

Transparency

Declaration of funding

This letter was not funded.

Declaration of financial/other relationships

The authors have no relevant financial relationships to disclose other than those already reported in their original article.

Acknowledgments

The authors would like to thank Prof. Rossella Di Bidino PhD MSc, health economist, external consultant of the Pricing and Reimbursement Committee, AIFA (Italian Medicines Agency) and Dr. Adam B. Smith PhD and Dr. Rob Hodgson PhD, statisticians at York Health Economics Consortium, University of York, for their valuable comments and suggestions in evaluating their results.